BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32865715)

  • 21. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models.
    Balboa-Barreiro V; Pértega-Díaz S; García-Rodríguez T; González-Martín C; Pardeiro-Pértega R; Yáñez-González-Dopeso L; Seoane-Pillado T
    Dig Liver Dis; 2024 Jul; 56(7):1229-1236. PubMed ID: 38087671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.
    Ozawa T; Hashiguchi Y; Yagi T; Fukushima Y; Shimada R; Hayama T; Tsuchiya T; Nozawa K; Iinuma H; Ishihara S; Matsuda K
    Int J Colorectal Dis; 2019 Oct; 34(10):1731-1739. PubMed ID: 31478086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Diameter is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer.
    Maeda C; Hidaka E; Mori Y; Mukai S; Miyachi H; Sawada N; Ishida F; Kudo SE
    Dig Surg; 2015; 32(5):338-43. PubMed ID: 26183549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of family history on survival in patients with colon and rectal cancer.
    Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis.
    Augestad KM; Bakaki PM; Rose J; Crawshaw BP; Lindsetmo RO; Dørum LM; Koroukian SM; Delaney CP
    Cancer Epidemiol; 2015 Oct; 39(5):734-44. PubMed ID: 26277328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
    Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
    World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.
    Chen DZ; Ji FY; Xu QM; Wu XX; Cai C; Zhang LJ; Li LJ
    Sci Rep; 2018 Jan; 8(1):972. PubMed ID: 29343809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.
    Mima K; Kurashige J; Miyanari N; Morito A; Yumoto S; Matsumoto T; Kosumi K; Inoue M; Mizumoto T; Kubota T; Baba H
    In Vivo; 2020; 34(1):339-346. PubMed ID: 31882497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposal of a stage-specific surveillance strategy for colorectal cancer patients: A retrospective analysis of Japanese large cohort.
    Okamura R; Hida K; Nishizaki D; Sugihara K; Sakai Y
    Eur J Surg Oncol; 2018 Apr; 44(4):449-455. PubMed ID: 29397263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence in patients with stage I colorectal cancer.
    Teloken PE; Ransom D; Faragher I; Jones I; Gibbs P; Platell C
    ANZ J Surg; 2016; 86(1-2):49-53. PubMed ID: 26235683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer.
    Yoda Y; Ikematsu H; Matsuda T; Yamaguchi Y; Hotta K; Kobayashi N; Fujii T; Oono Y; Sakamoto T; Nakajima T; Takao M; Shinohara T; Fujimori T; Kaneko K; Saito Y
    Endoscopy; 2013 Sep; 45(9):718-24. PubMed ID: 23918621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
    Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
    Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.
    Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.